Stryker (NYSE:SYK) Trading Down 6.2% – What’s Next?

Stryker Corporation (NYSE:SYK)’s share price was down 6.2% during mid-day trading on Tuesday . The stock traded as low as $286.28 and last traded at $284.2830. 852,923 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 2,347,572 shares. The stock had previously closed at $303.13.

Analyst Ratings Changes

Several brokerages recently issued reports on SYK. Raymond James Financial set a $370.00 price objective on Stryker in a research note on Friday, July 31st. JPMorgan Chase & Co. decreased their price target on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a research report on Friday, July 31st. Leerink Partners lowered their target price on Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Truist Financial increased their price target on shares of Stryker from $330.00 to $340.00 and gave the stock a “hold” rating in a research report on Friday, July 31st. Finally, Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Stryker presently has an average rating of “Moderate Buy” and an average target price of $386.28.

Stryker Price Performance

The firm has a market capitalization of $107.57 billion, a PE ratio of 29.08, a P/E/G ratio of 1.90 and a beta of 0.76. The company has a 50-day moving average price of $328.30 and a 200-day moving average price of $329.01. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period last year, the company earned $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts forecast that Stryker Corporation will post 15.03 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.3%. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

Insider Activity at Stryker

In other news, insider Dylan Crotty sold 441 shares of Stryker stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the sale, the insider owned 6,102 shares in the company, valued at $2,005,178.22. This trade represents a 6.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 300,000 shares of Stryker stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total value of $100,770,000.00. Following the sale, the director directly owned 2,301,375 shares in the company, valued at approximately $773,031,862.50. The trade was a 11.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 351,267 shares of company stock worth $118,197,701. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Stryker

A number of hedge funds have recently made changes to their positions in SYK. Sankala Group LLC bought a new stake in shares of Stryker in the 4th quarter valued at approximately $26,000. Godfrey Financial Associates Inc. bought a new position in shares of Stryker during the 4th quarter valued at $26,000. United Financial Planning Group LLC acquired a new stake in Stryker in the 3rd quarter worth approximately $27,000. Atlas Capital Advisors Inc. bought a new stake in Stryker during the fourth quarter worth approximately $27,000. Finally, Gables Capital Management Inc. bought a new position in shares of Stryker in the second quarter valued at approximately $25,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.